BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15781238)

  • 21. Alterations in internal elastic lamina permeability as a function of age and anatomical site precede lesion development in apolipoprotein E-null mice.
    Lee K; Forudi F; Saidel GM; Penn MS
    Circ Res; 2005 Sep; 97(5):450-6. PubMed ID: 16100042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angptl 4 deficiency improves lipid metabolism, suppresses foam cell formation and protects against atherosclerosis.
    Adachi H; Fujiwara Y; Kondo T; Nishikawa T; Ogawa R; Matsumura T; Ishii N; Nagai R; Miyata K; Tabata M; Motoshima H; Furukawa N; Tsuruzoe K; Kawashima J; Takeya M; Yamashita S; Koh GY; Nagy A; Suda T; Oike Y; Araki E
    Biochem Biophys Res Commun; 2009 Feb; 379(4):806-11. PubMed ID: 19094966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The absence of p53 accelerates atherosclerosis by increasing cell proliferation in vivo.
    Guevara NV; Kim HS; Antonova EI; Chan L
    Nat Med; 1999 Mar; 5(3):335-9. PubMed ID: 10086392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic deletion of pregnancy-associated plasma protein-A is associated with resistance to atherosclerotic lesion development in apolipoprotein E-deficient mice challenged with a high-fat diet.
    Harrington SC; Simari RD; Conover CA
    Circ Res; 2007 Jun; 100(12):1696-702. PubMed ID: 17510462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice.
    Secchiero P; Candido R; Corallini F; Zacchigna S; Toffoli B; Rimondi E; Fabris B; Giacca M; Zauli G
    Circulation; 2006 Oct; 114(14):1522-30. PubMed ID: 17000905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deficiency of inducible NO synthase reduces advanced but not early atherosclerosis in apolipoprotein E-deficient mice.
    Miyoshi T; Li Y; Shih DM; Wang X; Laubach VE; Matsumoto AH; Helm GA; Lusis AJ; Shi W
    Life Sci; 2006 Jul; 79(6):525-31. PubMed ID: 16516241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attenuation of accumulation of neointimal lipid by pioglitazone in mice genetically deficient in insulin receptor substrate-2 and apolipoprotein E.
    Clough MH; Schneider DJ; Sobel BE; White MF; Wadsworth MP; Taatjes DJ
    J Histochem Cytochem; 2005 May; 53(5):603-10. PubMed ID: 15872053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of the unfolded protein response occurs at all stages of atherosclerotic lesion development in apolipoprotein E-deficient mice.
    Zhou J; Lhoták S; Hilditch BA; Austin RC
    Circulation; 2005 Apr; 111(14):1814-21. PubMed ID: 15809369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of C-reactive protein in atherogenesis: can the apolipoprotein E knockout mouse provide the answer?
    Reifenberg K; Lehr HA; Baskal D; Wiese E; Schaefer SC; Black S; Samols D; Torzewski M; Lackner KJ; Husmann M; Blettner M; Bhakdi S
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1641-6. PubMed ID: 15920030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) enhances vascular and renal damage induced by hyperlipidemic diet in ApoE-knockout mice.
    Muñoz-García B; Moreno JA; López-Franco O; Sanz AB; Martín-Ventura JL; Blanco J; Jakubowski A; Burkly LC; Ortiz A; Egido J; Blanco-Colio LM
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2061-8. PubMed ID: 19778942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allograft inflammatory factor-1 augments macrophage phagocytotic activity and accelerates the progression of atherosclerosis in ApoE-/- mice.
    Mishima T; Iwabuchi K; Fujii S; Tanaka SY; Ogura H; Watano-Miyata K; Ishimori N; Andoh Y; Nakai Y; Iwabuchi C; Ato M; Kitabatake A; Tsutsui H; Onoé K
    Int J Mol Med; 2008 Feb; 21(2):181-7. PubMed ID: 18204784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mulberry leaf powder prevents atherosclerosis in apolipoprotein E-deficient mice.
    Harauma A; Murayama T; Ikeyama K; Sano H; Arai H; Takano R; Kita T; Hara S; Kamei K; Yokode M
    Biochem Biophys Res Commun; 2007 Jul; 358(3):751-6. PubMed ID: 17506985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice.
    Nachtigal P; Pospisilova N; Jamborova G; Pospechova K; Solichova D; Andrys C; Zdansky P; Micuda S; Semecky V
    Life Sci; 2008 Mar; 82(13-14):708-17. PubMed ID: 18289605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased levels of lipid peroxidation-induced DNA damage in the onset of atherogenesis in apolipoprotein E deficient mice.
    Godschalk RW; Albrecht C; Curfs DM; Schins RP; Bartsch H; van Schooten FJ; Nair J
    Mutat Res; 2007 Aug; 621(1-2):87-94. PubMed ID: 17418875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pomegranate byproduct administration to apolipoprotein e-deficient mice attenuates atherosclerosis development as a result of decreased macrophage oxidative stress and reduced cellular uptake of oxidized low-density lipoprotein.
    Rosenblat M; Volkova N; Coleman R; Aviram M
    J Agric Food Chem; 2006 Mar; 54(5):1928-35. PubMed ID: 16506855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mouse models of experimental atherosclerosis.
    Jawień J; Nastałek P; Korbut R
    J Physiol Pharmacol; 2004 Sep; 55(3):503-17. PubMed ID: 15381823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conditional knockout of macrophage PPARgamma increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice.
    Babaev VR; Yancey PG; Ryzhov SV; Kon V; Breyer MD; Magnuson MA; Fazio S; Linton MF
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1647-53. PubMed ID: 15947238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minimally oxidized LDL offsets the apoptotic effects of extensively oxidized LDL and free cholesterol in macrophages.
    Boullier A; Li Y; Quehenberger O; Palinski W; Tabas I; Witztum JL; Miller YI
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1169-76. PubMed ID: 16484596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF
    Circulation; 2007 Sep; 116(12):1404-12. PubMed ID: 17724261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
    Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
    Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.